Assura PLC

Director's Dealing • Jun 4, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1243B

Assura PLC

04 June 2019

4 June 2019

Assura plc

("the Company")

Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that Jayne Cottam, CFO and PDMR, has purchased 47,200 Ordinary Shares of 10 pence each in the Company ("Ordinary Shares") in accordance with the shareholding requirement section of the remuneration policy. Following the purchase, the total beneficial interest of Jayne Cottam and her connected persons in the Ordinary shares is 90,743 Ordinary Shares. The shares were purchased in two tranches.

The Notification of Dealing Form for the PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jayne Cottam

2

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Share purchase for 63.54 pence per share

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.6354 GBP	8,400

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price	Aggregate Volume	Aggregate Total
£0.6354 GBP	8,400	£5,337.36 GBP

e)

Date of the transaction

4/06/2018

f)

Place of the transaction

XLON

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jayne Cottam

2

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Share purchase for 64.05 pence per share

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£0.6405 GBP	38,800

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price	Aggregate Volume	Aggregate Total
£0.6405 GBP	38,800	£24,851.40 GBP

e)

Date of the transaction

3/06/2018

f)

Place of the transaction

XLON

For more information, please contact:

Assura plc	Tel: 01925 420660
Orla Ball
David Purcell
Finsbury	Tel: 0207 251 3801
Gordon Simpson

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHGMGGVDDVGLZM